PharmacoEconomics & Outcomes News

, Volume 817, Issue 1, pp 20–20 | Cite as

Ixekizumab cost effective versus secukinumab for plaque psoriasis

Clinical study


  1. Johannson E, et al. Cost effectiveness of ixekizumab versus secukinumab in the treatment of moderate-to-severe plaque psoriasis in Spain. ClinicoEconomics and Outcomes Research 2018: 747-759, No. 10, 12 Nov 2018. Available from: URL: CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations